Routine coronary angiography and revascularization in patients with non-ST-segment elevation acute coronary syndromes (NSTEACS) have been shown to be of benefit.1,2 However, these patients are at an increased risk of bleeding due to antiplatelet drugs, anticoagulants and invasive procedures. Major bleeding in patients with NSTEACS has been associated with increased risk of mortality.3-5 Vascula...